Protagonist presents one-year data for psoriasis drug ICOTYDE
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
NEWARK, Calif. - Protagonist Therapeutics Inc. (NASDAQ:PTGX) presented one-year Phase 3 data for ICOTYDE at the 2026 American Academy of Dermatology Annual Meeting on Friday, according to a company press release.
Read full article at source